Literature DB >> 26375727

A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.

Jun-Ichiro Kuroda1, Sumihito Nobusawa2, Hideo Nakamura1, Hideaki Yokoo2, Ryuta Ueda3, Keishi Makino1, Shigetoshi Yano1, Jun-ichi Kuratsu1.   

Abstract

Epithelioid glioblastomas are one of the rarest histological variants of glioblastomas, which are not formally recognized by the World Health Organization (WHO) classification. Epithelioid glioblastomas usually occur as primary lesions, but there have been several reports of secondary epithelioid glioblastomas or epithelioid glioblastomas with pre- or co-existing lesions to date. The serine/threonine-protein kinase B-Raf (BRAF) V600E mutation has been found at a high frequency of 54% in epithelioid glioblastomas. We present a case of a 26-year-old female patient with an epithelioid glioblastoma with the BRAF V600E mutation in her right frontal lobe. In the present case, a low-grade diffuse astrocytoma component had colocalized with the epithelioid glioblastoma. The component presented prominent calcification on neuroimages as well as by histology, and low-grade diffuse astrocytoma was considered to be a precursor lesion of an epithelioid glioblastoma. However, the BRAF V600E mutation was detected only in epithelioid glioblastoma but not in low-grade diffuse astrocytoma. To the best of our knowledge, this is the first report demonstrating a discrepancy in the BRAF V600E mutation states between epithelioid glioblastoma and colocalized low-grade astrocytoma.
© 2015 Japanese Society of Neuropathology.

Entities:  

Keywords:  BRAF V600E mutation; dissemination; epithelioid glioblastoma; low-grade diffuse astrocytoma; metastasis

Mesh:

Substances:

Year:  2015        PMID: 26375727     DOI: 10.1111/neup.12258

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  7 in total

1.  Clinicopathological characteristics and treatment outcomes of epithelioid glioblastoma.

Authors:  Kaijun Sun; Xingwang Zhou; Tengfei Li; Mingrong Zuo; Junhong Li; Yanhui Liu
Journal:  Neurosurg Rev       Date:  2021-02-17       Impact factor: 3.042

2.  Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.

Authors:  Andrey Korshunov; Lukas Chavez; Tanvi Sharma; Marina Ryzhova; Daniel Schrimpf; Damian Stichel; David Capper; Dominik Sturm; Marcel Kool; Antje Habel; Bette K Kleinschmidt-DeMasters; Marc Rosenblum; Oksana Absalyamova; Andrey Golanov; Peter Lichter; Stefan M Pfister; David T W Jones; Arie Perry; Andreas von Deimling
Journal:  Brain Pathol       Date:  2017-10-30       Impact factor: 6.508

3.  Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation.

Authors:  Garry Ceccon; Jan-Michael Werner; Veronika Dunkl; Caroline Tscherpel; Gabriele Stoffels; Anna Brunn; Martina Deckert; Gereon R Fink; Norbert Galldiks
Journal:  Int J Mol Sci       Date:  2018-04-05       Impact factor: 5.923

4.  Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.

Authors:  Yu Kanemaru; Manabu Natsumeda; Masayasu Okada; Rie Saito; Daiki Kobayashi; Takeyoshi Eda; Jun Watanabe; Shoji Saito; Yoshihiro Tsukamoto; Makoto Oishi; Hirotake Saito; Masayuki Nagahashi; Takahiro Sasaki; Rintaro Hashizume; Hidefumi Aoyama; Toshifumi Wakai; Akiyoshi Kakita; Yukihiko Fujii
Journal:  Acta Neuropathol Commun       Date:  2019-07-25       Impact factor: 7.801

5.  Clinicopathological, Immunohistochemical and Molecular Genetic Study on Epithelioid Glioblastoma: A Series of Fifteen Cases with Literature Review.

Authors:  Ying Zeng; Xiangfeng Zhu; Yali Wang; Bo Liu; Xin Yang; Qiushi Wang; Juan Du; Yu Ma; Li Lin; Ping Fu; Hualiang Xiao; Qiao-Nan Guo
Journal:  Onco Targets Ther       Date:  2020-05-08       Impact factor: 4.147

6.  Less-invasive diagnosis of disseminated epithelioid glioblastoma harboring BRAF V600E mutation by cerebrospinal fluid analysis-A case report.

Authors:  Manabu Natsumeda; Yu Kanemaru; Yukie Kawaguchi; Hajime Umezu; Akiyoshi Kakita; Yukihiko Fujii
Journal:  Clin Case Rep       Date:  2021-07-16

7.  Epithelioid glioblastoma presenting as multicentric glioma: A case report and review of the literature.

Authors:  Daisuke Kohno; Akihiro Inoue; Mana Fukushima; Tomoharu Aki; Shirabe Matsumoto; Satoshi Suehiro; Masahiro Nishikawa; Saya Ozaki; Seiji Shigekawa; Hideaki Watanabe; Riko Kitazawa; Takeharu Kunieda
Journal:  Surg Neurol Int       Date:  2020-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.